• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

观察或放疗组听神经瘤人工耳蜗植入患者的听力康复效果:系统评价。

Hearing rehabilitation outcomes in cochlear implant recipients with vestibular schwannoma in observation or radiotherapy groups: A systematic review.

机构信息

Cambridge Skull Base Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

University of Cambridge Medical Library, Cambridge, UK.

出版信息

Cochlear Implants Int. 2020 Jan;21(1):9-17. doi: 10.1080/14670100.2019.1662161. Epub 2019 Sep 8.

DOI:10.1080/14670100.2019.1662161
PMID:31496442
Abstract

Vestibular schwannomas (VS) are rare benign tumours of the vestibular nerve that cause hearing loss. Management strategies include watchful waiting, radiotherapy or surgical resection. Historically, the presence of retrocochlear disease has been considered to be a contra-indication to cochlear implantation (CI). The aim of this systematic review is to assess hearing rehabilitation outcomes for CI recipients with VS, either sporadic or associated with neurofibromatosis type 2, whose tumours have been managed with either observation or radiotherapy. PubMed, Embase, and Cochrane Library databases were searched from inception through to November 2018. 50 cases from 12 studies met the inclusion criteria. Patient demographics, VS characteristics, management strategy, pre-CI hearing status, electrical promontory stimulation testing, post-CI hearing status and speech perception scores, functional benefits and follow-up length are reported. Radiotherapy and observation groups had similar patient demographics in terms of age at CI, tumour size and duration of deafness. Following CI, 64% and 60% of patients in the radiotherapy and observation groups achieved open-set speech perception, respectively. Pure tone average thresholds (33 vs. 39 dB) and speech scores were also comparable between both groups. Ipsilateral CI in patients with VS that have not been surgically resected can provide beneficial hearing rehabilitation outcomes.

摘要

前庭神经鞘瘤(VS)是一种罕见的前庭神经良性肿瘤,可导致听力损失。治疗策略包括密切观察、放疗或手术切除。从历史上看,耳蜗后疾病的存在被认为是耳蜗植入(CI)的禁忌症。本系统评价的目的是评估接受 VS 治疗的 CI 患者(无论是散发性还是与 2 型神经纤维瘤病相关)的听力康复结果,这些肿瘤通过观察或放疗进行管理。从建立到 2018 年 11 月,对 PubMed、Embase 和 Cochrane Library 数据库进行了检索。12 项研究中的 50 例符合纳入标准。报告了患者人口统计学、VS 特征、管理策略、CI 前听力状况、电刺激测试、CI 后听力状况和言语感知评分、功能获益和随访时间。放疗组和观察组在 CI 年龄、肿瘤大小和耳聋持续时间方面的患者人口统计学特征相似。CI 后,放疗组和观察组分别有 64%和 60%的患者获得开放式言语感知。两组的纯音平均阈值(33 与 39dB)和言语评分也相似。未行手术切除的 VS 患者同侧 CI 可提供有益的听力康复效果。

相似文献

1
Hearing rehabilitation outcomes in cochlear implant recipients with vestibular schwannoma in observation or radiotherapy groups: A systematic review.观察或放疗组听神经瘤人工耳蜗植入患者的听力康复效果:系统评价。
Cochlear Implants Int. 2020 Jan;21(1):9-17. doi: 10.1080/14670100.2019.1662161. Epub 2019 Sep 8.
2
Cochlear implantation after radiosurgery for vestibular schwannoma.放射外科治疗前庭神经鞘瘤后的耳蜗植入。
J Neurosurg. 2021 Jul 1;135(1):126-135. doi: 10.3171/2020.4.JNS201069. Epub 2021 Jun 24.
3
Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas.存在观察到的和接受过放疗的前庭神经鞘瘤时的同侧人工耳蜗植入术。
Ann Otol Rhinol Laryngol. 2020 Dec;129(12):1229-1238. doi: 10.1177/0003489420935482. Epub 2020 Jun 18.
4
Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.2 型神经纤维瘤病患者的耳蜗植入:影响听觉表现的变量。
Otol Neurotol. 2012 Jul;33(5):853-62. doi: 10.1097/MAO.0b013e318254fba5.
5
Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.2型神经纤维瘤病合并双侧前庭神经鞘瘤患者的人工耳蜗植入
Otol Neurotol. 2006 Jun;27(4):512-8. doi: 10.1097/01.mao.0000217351.86925.51.
6
Cochlear implants to treat deafness caused by vestibular schwannomas.人工耳蜗植入术治疗前庭神经鞘瘤引起的耳聋。
Otol Neurotol. 2013 Sep;34(7):1291-8. doi: 10.1097/MAO.0b013e31829763a7.
7
Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.人工耳蜗在2型神经纤维瘤病听力损失管理中的应用
Cochlear Implants Int. 2017 May;18(3):171-179. doi: 10.1080/14670100.2017.1300723. Epub 2017 Mar 24.
8
Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation.小儿2型神经纤维瘤病:临床与分子表现、前庭神经鞘瘤的管理及听力康复
Childs Nerv Syst. 2016 Dec;32(12):2403-2413. doi: 10.1007/s00381-016-3257-1. Epub 2016 Oct 4.
9
Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2.2型神经纤维瘤病的人工耳蜗植入和听觉脑干植入
Laryngoscope. 2018 Sep;128(9):2163-2169. doi: 10.1002/lary.27181. Epub 2018 Mar 24.
10
Outcomes of cochlear implantation in patients with neurofibromatosis type 2.2型神经纤维瘤病患者人工耳蜗植入的效果
Cochlear Implants Int. 2016 Jul;17(4):172-177. doi: 10.1080/14670100.2016.1197587.

引用本文的文献

1
Cochlear Implantation for Sensorineural Hearing Loss Related to Cochlear Aqueduct Obstruction by a Jugular Foramen Tumor.经颈静脉孔肿瘤致蜗水管阻塞相关感音神经性听力损失的人工耳蜗植入术
Laryngoscope Investig Otolaryngol. 2025 Aug 27;10(4):e70171. doi: 10.1002/lio2.70171. eCollection 2025 Aug.
2
Cochlear Implants and the Aided Audiogram: A Retrospective Study Comparing Performance Across Device Manufacturers.人工耳蜗与助听听阈图:一项比较不同设备制造商性能的回顾性研究。
Audiol Res. 2025 Jul 2;15(4):79. doi: 10.3390/audiolres15040079.
3
Brazilian Society of Otology task force - cochlear implant ‒ recommendations based on strength of evidence.
巴西耳科学会特别工作组 - 人工耳蜗植入 - 基于证据强度的建议
Braz J Otorhinolaryngol. 2025 Jan-Feb;91(1):101512. doi: 10.1016/j.bjorl.2024.101512. Epub 2024 Sep 16.
4
How Cochlear Implant Rehabilitation Impacts the Therapeutic Strategy for Vestibular Schwannoma.人工耳蜗康复如何影响前庭神经鞘瘤的治疗策略。
Audiol Res. 2023 Feb 8;13(1):116-129. doi: 10.3390/audiolres13010012.
5
Current Understanding of Hearing Loss in Sporadic Vestibular Schwannomas: A Systematic Review.散发性前庭神经鞘瘤听力损失的当前认识:一项系统综述。
Front Oncol. 2021 Aug 12;11:687201. doi: 10.3389/fonc.2021.687201. eCollection 2021.
6
Management of transmodiolar and transmacular cochleovestibular schwannomas with and without cochlear implantation.经耳蜗植入和未经耳蜗植入的跨耳蜗和跨迷路耳蜗前庭神经鞘瘤的治疗管理。
HNO. 2021 Jan;69(Suppl 1):7-19. doi: 10.1007/s00106-020-00919-9.
7
[Hearing classification in patients with vestibular schwannoma using German-language test procedures].[使用德语测试程序对前庭神经鞘瘤患者进行听力分类]
HNO. 2021 Sep;69(9):750-758. doi: 10.1007/s00106-020-00948-4. Epub 2020 Sep 25.